Current Appointments & Affiliations
Associate Professor of Radiation Oncology
·
2021 - Present
Radiation Oncology,
Clinical Science Departments
Member of the Duke Cancer Institute
·
2010 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal Article J Natl Compr Canc Netw · January 2025 Dermatofibrosarcoma protuberans (DFSP) is a rare cutaneous soft tissue sarcoma and affects an estimated 1,500 people annually in the United States. DFSP frequently exhibits extensive local infiltration. Initial treatment is through surgical excision, and c ... Full text Link to item CiteUnderstanding and modeling human-AI interaction of artificial intelligence tool in radiation oncology clinic using deep neural network: a feasibility study using three year prospective data.
Journal Article Phys Med Biol · November 14, 2024 Objective.Artificial intelligence (AI) based treatment planning tools are being implemented in clinic. However, human interactions with such AI tools are rarely analyzed. This study aims to comprehend human planner's interaction with the AI planning tool a ... Full text Link to item CiteNCCN Guidelines® Insights: Merkel Cell Carcinoma, Version 1.2024.
Journal Article J Natl Compr Canc Netw · January 2024 The NCCN Guidelines for Merkel Cell Carcinoma (MCC) provide recommendations for diagnostic workup, clinical stage, and treatment options for patients. The panel meets annually to discuss updates to the guidelines based on comments from expert review from p ... Full text Link to item CiteRecent Grants
TBCRC053-N Protocol Title: "P-RAD: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, HER2-Negative Breast Cancer (Triple Negative Cohort Only)"
Clinical TrialPrincipal Investigator · Awarded by Johns Hopkins University · 2022 - 2027TBCRC053-M-59105
Clinical TrialPrincipal Investigator · Awarded by Merck Sharp & Dohme · 2023 - 2027P-RAD: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, HER2-Negative Breast Cancer
Clinical TrialPrincipal Investigator · Awarded by Johns Hopkins University · 2024 - 2026View All Grants
Education, Training & Certifications
Tufts University ·
2005
MD./PhD.